quizartinib
daiichi sankyo
['quantum-first']
 seems consistent with the analysis from quantum-first, which also showed an advantage for the quiz arm after hsct specifically in pts mrd+ pre-transplant. post-hsct tki maintenance only if mrd+? 
Physician-scientist, leukemia geneticist, amateur photographer